InvestorsHub Logo
Post# of 174186
Next 10
Followers 10
Posts 1600
Boards Moderated 0
Alias Born 09/29/2018

Re: None

Thursday, 09/01/2022 7:44:15 AM

Thursday, September 01, 2022 7:44:15 AM

Post# of 174186
Positive progress. Test plan submitted, risk management report submitted, presently and actively involved with John’s Hopkins, meeting requested, and

“RadioGel™ Risk Management Report. This report considers all the plausible scenarios for risks related to Precision Radionuclide Therapy. It concludes in all scenarios that our product is safe, the patient risks are insignificant, and RadioGel™ has the highest Therapeutic Ratio of any product currently on the market.”

??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News